M.tuberculosis - M.bovis

Currently, there is a significant increase in the global incidence of tuberculosis: nearly 8 million new cases are reported annually. Approximately 3 million people die from the disease every year.

At present, the initial laboratory analysis of specimens for detection of the causative agent is performed in general medical institutions using direct microscopy. The more informative culture-based examination is conducted exclusively in bacteriological laboratories of specialized tuberculosis facilities at regional and major centers.

However, routine diagnostics and typing of Mycobacterium tuberculosis using microbiological methods take from 3 weeks to 3 months, which can adversely affect the effectiveness of treatment. Moreover, the epidemiological landscape of the disease has changed: there is an annual increase in cases of primary tuberculosis caused by strains resistant to one or more antimycobacterial drugs. Conventional antibiotic therapy is often ineffective for such patients, as the infection tends to be severe and rapidly progressive. Consequently, there is an urgent need for rapid detection of drug-resistant strains.

The use of real-time PCR for diagnosis enables highly sensitive analysis, which can be implemented both in specialized facilities and in general medical institutions at the initial stage of testing.

The M.tuberculosis - M.bovis REAL-TIME PCR Detection Kit is an in vitro Nucleic Acid Test (NAT) – pathogen-detection-based product.

The M.tuberculosis - M.bovis REAL-TIME PCR Detection Kit is designed to detect Mycobacterium tuberculosis and Mycobacterium bovis nucleic acids in human biological samples by Polymerase Chain Reaction (PCR) method.

The M.tuberculosis - M.bovis REAL-TIME PCR Detection Kit is intended for research and diagnostic applications.

Certification: CE/IVD